T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Medtronic
MDT
$116B
| $589M | 0.13% |
8,162,157
+5,959,711
| +271% | +$414M |
|
202
Blackrock
BLK
$178B
| $579M | 0.12% |
1,620,207
-182,946
| -10% | -$62.5M |
|
203
Universal Health Services
UHS
$9.94B
| $579M | 0.12% |
5,202,139
+165,836
| +3% | +$17.4M |
|
204
AvalonBay Communities
AVB
$26B
| $578M | 0.12% |
3,534,840
-116,678
| -3% | -$18.3M |
|
205
Western Union
WU
$2.2B
| $567M | 0.12% |
31,655,749
+2,039,131
| +7% | +$35.4M |
|
|
VIAB
206
DELISTED
Viacom Inc. Class B
VIAB
| $567M | 0.12% |
7,532,416
+494,550
| +7% | +$36.1M |
|
207
Coca-Cola
KO
$372B
| $560M | 0.12% |
13,253,587
-1,144,808
| -8% | -$48.9M |
|
208
Equifax
EFX
$21.4B
| $559M | 0.12% |
6,910,377
+481,146
| +7% | +$37.2M |
|
209
Acuity Brands
AYI
$10.7B
| $556M | 0.12% |
3,968,660
-343,246
| -8% | -$46.6M |
|
210
Mondelez International
MDLZ
$78.9B
| $547M | 0.12% |
15,060,024
-1,726,675
| -10% | -$62.8M |
|
211
Workday
WDAY
$44.8B
| $543M | 0.12% |
6,659,397
+1,146,400
| +21% | +$99M |
|
|
ETFC
212
DELISTED
E*Trade Financial Corporation
ETFC
| $541M | 0.11% |
22,295,425
-775,801
| -3% | -$17.4M |
|
|
XL
213
DELISTED
XL Group Ltd.
XL
| $536M | 0.11% |
15,598,489
-5,804,601
| -27% | -$198M |
|
214
Cboe Global Markets
CBOE
$29.5B
| $534M | 0.11% |
8,420,877
+870,994
| +12% | +$52M |
|
215
Western Digital
WDC
$151B
| $529M | 0.11% |
6,316,529
-676,901
| -10% | -$51.1M |
|
|
SIRO
216
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $525M | 0.11% |
6,009,237
-3,132
| -0.1% | -$259K |
|
217
Puma Biotechnology
PBYI
$453M
| $524M | 0.11% |
2,766,701
-772,722
| -22% | -$171M |
|
|
HOT
218
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $515M | 0.11% |
6,355,248
-2,864,472
| -31% | -$223M |
|
219
Murphy Oil
MUR
$5.12B
| $514M | 0.11% |
10,177,610
+1,044,858
| +11% | +$53.5M |
|
|
TWC
220
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $514M | 0.11% |
3,380,493
-2,360,381
| -41% | -$341M |
|
221
Bruker
BRKR
$8.69B
| $512M | 0.11% |
26,104,810
+2,659,400
| +11% | +$51.2M |
|
|
PX
222
DELISTED
Praxair Inc
PX
| $510M | 0.11% |
3,936,672
-1,776,509
| -31% | -$225M |
|
223
Teleflex
TFX
$5.91B
| $509M | 0.11% |
4,429,180
+1,044,670
| +31% | +$118M |
|
|
TWTR
224
DELISTED
Twitter, Inc.
TWTR
| $507M | 0.11% |
14,136,156
+10,303,948
| +269% | +$439M |
|
225
Quest Diagnostics
DGX
$26.2B
| $505M | 0.11% |
7,528,526
+391,145
| +5% | +$24.7M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.